123 related articles for article (PubMed ID: 38458405)
1. Dexamethasone nanomedicines with optimized drug release kinetics tailored for treatment of site-specific rheumatic musculoskeletal diseases.
Libánská A; Randárová E; Rubanová D; Skoroplyas S; Bryja J; Kubala L; Konefal R; Navrátilová A; Cerezo LA; Šenolt L; Etrych T
Int J Pharm; 2024 Apr; 654():123979. PubMed ID: 38458405
[TBL] [Abstract][Full Text] [Related]
2. Size-switchable polymer-based nanomedicines in the advanced therapy of rheumatoid arthritis.
Libánská A; Randárová E; Skoroplyas S; Bartoš M; Luňáčková J; Lager F; Renault G; Scherman D; Etrych T
J Control Release; 2023 Jan; 353():30-41. PubMed ID: 36403682
[TBL] [Abstract][Full Text] [Related]
3. Bloodstream Stability Predetermines the Antitumor Efficacy of Micellar Polymer-Doxorubicin Drug Conjugates with pH-Triggered Drug Release.
Chytil P; Šírová M; Kudláčová J; Říhová B; Ulbrich K; Etrych T
Mol Pharm; 2018 Sep; 15(9):3654-3663. PubMed ID: 29543465
[TBL] [Abstract][Full Text] [Related]
4. Highly effective anti-tumor nanomedicines based on HPMA copolymer conjugates with pirarubicin prepared by controlled RAFT polymerization.
Randárová E; Nakamura H; Islam R; Studenovský M; Mamoru H; Fang J; Chytil P; Etrych T
Acta Biomater; 2020 Apr; 106():256-266. PubMed ID: 32058082
[TBL] [Abstract][Full Text] [Related]
5. Polymer Nanomedicines with Ph-Sensitive Release of Dexamethasone for the Localized Treatment of Inflammation.
Libánská A; Randárová E; Lager F; Renault G; Scherman D; Etrych T
Pharmaceutics; 2020 Jul; 12(8):. PubMed ID: 32722403
[TBL] [Abstract][Full Text] [Related]
6. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H
Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482
[TBL] [Abstract][Full Text] [Related]
7. Polymer conjugates of doxorubicin bound through an amide and hydrazone bond: Impact of the carrier structure onto synergistic action in the treatment of solid tumours.
Etrych T; Subr V; Laga R; Ríhová B; Ulbrich K
Eur J Pharm Sci; 2014 Jul; 58():1-12. PubMed ID: 24632485
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Characterization of Novel Succinyl Chitosan-Dexamethasone Conjugates for Potential Intravitreal Dexamethasone Delivery.
Dubashynskaya NV; Bokatyi AN; Golovkin AS; Kudryavtsev IV; Serebryakova MK; Trulioff AS; Dubrovskii YA; Skorik YA
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681619
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral Distribution and pH-Dependent Drug Release of High Molecular Weight HPMA Copolymer Drug Conjugates Strongly Depend on Specific Tumor Substructure and Microenvironment.
Noack AK; Lucas H; Chytil P; Etrych T; Mäder K; Mueller T
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825790
[TBL] [Abstract][Full Text] [Related]
10. Poly(2-ethyl-2-oxazoline) conjugates with doxorubicin for cancer therapy: In vitro and in vivo evaluation and direct comparison to poly[N-(2-hydroxypropyl)methacrylamide] analogues.
Sedlacek O; Monnery BD; Mattova J; Kucka J; Panek J; Janouskova O; Hocherl A; Verbraeken B; Vergaelen M; Zadinova M; Hoogenboom R; Hruby M
Biomaterials; 2017 Nov; 146():1-12. PubMed ID: 28892751
[TBL] [Abstract][Full Text] [Related]
11. HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity.
Etrych T; Strohalm J; Kovár L; Kabesová M; Ríhová B; Ulbrich K
J Control Release; 2009 Nov; 140(1):18-26. PubMed ID: 19632282
[TBL] [Abstract][Full Text] [Related]
12. Adaptable polymerization platform for therapeutics with tunable biodegradability.
Hrochová M; Kotrchová L; Frejková M; Konefał R; Gao S; Fang J; Kostka L; Etrych T
Acta Biomater; 2023 Nov; 171():417-427. PubMed ID: 37696413
[TBL] [Abstract][Full Text] [Related]
13. Tumor-targeted micelle-forming block copolymers for overcoming of multidrug resistance.
Braunová A; Kostka L; Sivák L; Cuchalová L; Hvězdová Z; Laga R; Filippov S; Černoch P; Pechar M; Janoušková O; Šírová M; Etrych T
J Control Release; 2017 Jan; 245():41-51. PubMed ID: 27871991
[TBL] [Abstract][Full Text] [Related]
14. HPMA-based polymer conjugates with drug combination.
Krakovicová H; Etrych T; Ulbrich K
Eur J Pharm Sci; 2009 Jun; 37(3-4):405-12. PubMed ID: 19491032
[TBL] [Abstract][Full Text] [Related]
15. Anti-Lymphoma Efficacy Comparison of Anti-Cd20 Monoclonal Antibody-Targeted and Non-Targeted Star-Shaped Polymer-Prodrug Conjugates.
Lidický O; Janoušková O; Strohalm J; Alam M; Klener P; Etrych T
Molecules; 2015 Nov; 20(11):19849-64. PubMed ID: 26556320
[TBL] [Abstract][Full Text] [Related]
16. Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacy.
Etrych T; Kovář L; Strohalm J; Chytil P; Ríhová B; Ulbrich K
J Control Release; 2011 Sep; 154(3):241-8. PubMed ID: 21699933
[TBL] [Abstract][Full Text] [Related]
17. New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties.
Etrych T; Jelínková M; Ríhová B; Ulbrich K
J Control Release; 2001 May; 73(1):89-102. PubMed ID: 11337062
[TBL] [Abstract][Full Text] [Related]
18. Designing polymer conjugates as lysosomotropic nanomedicines.
Duncan R
Biochem Soc Trans; 2007 Feb; 35(Pt 1):56-60. PubMed ID: 17233601
[TBL] [Abstract][Full Text] [Related]
19. Polymer nanomedicines with enzymatically triggered activation: A comparative study of in vitro and in vivo anti-cancer efficacy related to the spacer structure.
Pechar M; Pola R; Studenovský M; Bláhová M; Grosmanová E; Dydowiczová A; Filipová M; Islam R; Gao S; Fang J; Etrych T
Nanomedicine; 2022 Nov; 46():102597. PubMed ID: 36064033
[TBL] [Abstract][Full Text] [Related]
20. N-(2-Hydroxypropyl)methacrylamide-Based Linear, Diblock, and Starlike Polymer Drug Carriers: Advanced Process for Their Simple Production.
Koziolová E; Kostka L; Kotrchová L; Šubr V; Konefal R; Nottelet B; Etrych T
Biomacromolecules; 2018 Oct; 19(10):4003-4013. PubMed ID: 30180562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
